The Effectiveness and Efficacy of the Combination of Pharmacotherapy With the Two New Recovery-oriented Programs, RECOVERYTRSGR (Treatment Resistant Schizophrenia) and RECOVERYTRSBDGR (Treatment Resistant Bipolar Disorder)
Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant schizophrenia and RECOVERYTRSBDGR for patients with treatment- resistant bipolar disorder.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• age 18-65
• IQ ≥ 80
• Diagnosis TRS.
• age 18-65
• IQ ≥ 80
• Diagnosis TRSBD.
Locations
Other Locations
Greece
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
RECRUITING
Athens
Contact Information
Primary
Dr. Stavroula Rakitzi, PhD
Stavroula@Rakitzi.onmicrosoft.com
+306989766935
Backup
Dr. Polyxeni Georgila, M. D.
polyxenigeorgila@gmail.com
+306932905259
Time Frame
Start Date: 2025-06-04
Estimated Completion Date: 2027-12-20
Participants
Target number of participants: 40
Treatments
Experimental: Group A
Pharmacotherapy and RECOVERYTRSGR 20 participants
Active_comparator: Group B
Pharmacotherapy and TAU. 15 participants
Experimental: Group C
Pharmacotherapy and RECOVERYTRSBDGR. 15 participants
Active_comparator: Group D
Pharmacotherapy and TAU. 10 participants
Related Therapeutic Areas
Sponsors
Leads: Dr. Stavroula Rakitzi